Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.

Genest J, Frohlich J, Fodor G, McPherson R; Working Group on Hypercholesterolemia and Other Dyslipidemias.

CMAJ. 2003 Oct 28;169(9):921-4. No abstract available. Erratum in: CMAJ. 2003 Nov 25;169(11):1149.

2.

Clinical practice guidelines for the management of dyslipidemia.

Nichols N.

Can J Cardiovasc Nurs. 2004;14(2):7-10. Review.

PMID:
15230023
3.

[Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].

Ravera M, Paoletti E.

Ital Heart J Suppl. 2004 Jun;5(6):436-44. Review. Italian.

PMID:
15471148
4.

[Treatment for hypertension with metabolic disorders (DM etc)].

Shimamoto K, Miura T.

Nihon Rinsho. 2006 Aug;64 Suppl 6:513-9. Review. Japanese. No abstract available.

PMID:
16981585
5.

Cardiovascular risk factors in adolescents: relevance, detection, and intervention.

McCrindle BW.

Adolesc Med. 2001 Feb;12(1):147-62. Review.

PMID:
11224028
6.

Bimonthly update: lipidology. Hyperlipidaemia and cardiovascular disease.

Sussekov AV, Stekolschikova OD.

Curr Opin Lipidol. 2000 Oct;11(5):559-62. Review. No abstract available.

PMID:
11048899
7.

Metabolic syndrome: cardiovascular risk assessment and management.

Wong ND.

Am J Cardiovasc Drugs. 2007;7(4):259-72. Review.

PMID:
17696567
8.

[Primary prevention of cardiovascular disease].

Gohlke H.

Dtsch Med Wochenschr. 2005 Jan 7;130(1-2):38-43. Review. German. No abstract available.

PMID:
15619173
9.

[Treatment of patients with high cardiovascular risk in general practice].

Ilyés I, Erdei I, Jancsó Z.

Orv Hetil. 2004 Aug 15;145(33):1723-6. Review. Hungarian. No abstract available.

PMID:
15462478
10.

Common questions in managing hyperlipidemia.

Rosen IM, Sams RW 2nd.

Prim Care. 2006 Dec;33(4):903-21. Review.

PMID:
17169673
11.

[Lipid-lowering therapy in chronic kidney disease].

Fernández-Vega F.

Nefrologia. 2004;24 Suppl(6):113-26, 187-235. Review. Spanish. No abstract available.

12.

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); International Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); European Society of General Practice/Family Medicine (ESGP/FM/WONCA); European Heart Network (EHN).

Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:E1-40. No abstract available.

PMID:
17726406
13.

Bimonthly update: lipidology. Hyperlipidaemia and cardiovascular disease.

Dominiczak MH.

Curr Opin Lipidol. 1997 Dec;8(6):U84-5. Review. No abstract available.

PMID:
9440933
14.

[Cardiovascular risk factors and prevention].

Bongard V, Ferrières J.

Rev Prat. 2006 Jan 15;56(1):79-87, 94. Review. French. No abstract available.

PMID:
16548253
15.

Time for results: a better way to reduce cardiovascular risk.

Mola A, Lloyd M.

Adv Nurse Pract. 2002 Apr;10(4):34-41; quiz 42-3. Review. No abstract available.

PMID:
12418348
16.

Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.

Fazio S.

Clin Ther. 2008 Feb;30(2):294-306. doi: 10.1016/j.clinthera.2008.02.004. Review.

PMID:
18343268
17.

Managing cardiovascular risk in patients with HIV infection.

Stein JH.

J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):115-23. Review.

PMID:
15671795
18.

Dyslipidemia in the metabolic syndrome in children.

Gidding SS.

J Cardiometab Syndr. 2006 Summer;1(4):282-5. Review.

19.

Reducing CVD risk - integration of clinical and laboratory criteria.

Tognarini DP, Sullivan DR, Thomas DW, Sikaris K.

Aust Fam Physician. 2008 Jun;37(6):422-7. Review.

20.

Evidence-based management of dyslipidemias in women.

LaRosa JC.

Curr Atheroscler Rep. 2003 Sep;5(5):379-85. Review. No abstract available.

PMID:
12911848

Supplemental Content

Support Center